Ginkgo Bioworks Holdings, Inc. Liquidation Value

DNA Other

Cash & Equivalents

$167.20M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $167.20M
Total Obligations: -$535.86M
$-368.65M
Per share: $-6.33
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $167.20M
AR: $24.03M
Total Obligations: -$535.86M
$-344.63M
Per share: $-5.92
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $167.20M
AR: $24.03M
Inventory: $0
Total Obligations: -$535.86M
$-344.63M
Per share: $-5.92
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-368.65M$-6.33
Liquid Liquidation Value$-344.63M$-5.92
Operating Liquidation Value$-344.63M$-5.92

Key Components (as of 2025-12-31)

Cash & Equivalents$167.20M
Accounts Receivable$24.03M
InventoryN/A
Current Liabilities$95.97M
Long-term DebtN/A
Op. Lease Liability$439.87M
Finance Lease$20,000
Shares Outstanding58.2M

Explore all 262 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$167.20M$24.03MN/A$10.57M$95.97MN/A$439.87M$20,000
2025-09-30$111.06M$21.43MN/A$10.70M$115.28MN/A$422.87MN/A
2025-06-30$203.57M$22.15MN/A$11.20M$96.72MN/A$428.83MN/A
2025-03-31$312.42M$26.29MN/A$11.27M$115.67MN/A$434.56MN/A
2024-12-31$561.57M$21.86MN/A$14.17M$107.27MN/A$467.40M$361,000
2024-09-30$616.21M$23.41MN/A$15.70M$114.43MN/A$445.59MN/A
2024-06-30$730.37M$18.59MN/A$23.03M$166.15MN/A$452.26MN/A
2024-04-30N/AN/AN/AN/AN/AN/A$223.90MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-26 View
2025-09-30 10-Q 2025-11-06 View
2025-06-30 10-Q 2025-08-07 View
2025-03-31 10-Q 2025-05-06 View
2024-12-31 10-K 2025-02-25 View
2024-09-30 10-Q 2024-11-12 View
2024-06-30 10-Q 2024-08-08 View
2024-03-31 10-Q 2024-05-09 View

Community Notes

Loading notes...

Questions

Loading questions...